Clarke et al. [5] demonstrated that BMCC1 RNA expression is elevated in prostate cancer and metastases compared with benign tissue, indicating that BMCC1 may be functioning differently in different cancers and tissue types. Here, PRUNE2 is linked to prostate carcinoma.